High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To assess the treatment outcome benefit of multiagent consolidation in young adults
with acute myeloid leukemia (AML) in a prospective, randomized, multicenter trial.